UBC is a global pharmaceutical services organization that combines deep scientific knowledge with broad operational expertise to meet the growing demands for strategic execution of post approval programs.
Our focus is on generating real-world data to support the development and commercialization of medical products for emerging and established life science companies.
We partner with our clients to offer services in scientific research and strategic consulting, late stage clinical development, post-approval registries and drug safety, data integration and analysis, clinical technologies, investigator services and medical education, patient recruiting, and market access services. UBC’s industry-leading risk management and epidemiology experts help clients appropriately balance the benefits and risks of innovative medicines and medical technology.
UBC specializes in offering innovative ways to study drugs and devices with an emphasis on science, strategy, and execution.